Double Bond Pharmaceutical International
0,12
SEK
-7,69 %
Mindre end 1K følgere
DBP B
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Overview
Ownership
Investor consensus
-7,69%
+4,35%
-61,95%
-66,02%
-68,01%
-73,43%
-70,88%
-95,73%
-95,88%
Double Bond Pharmaceutical, DBP, is a pharmaceutical company. The company's business focus is on the treatment of cancer, infections and autoimmune diseases. The research is based on the company's proprietary drug-delivery technology. The products are sold under separate brands and product development collaborations take place with other players in the industry. The company is headquartered in Uppsala.
Læs mereMarkedsværdi
24,69 mio. SEK
Aktieomsætning
35,72 t SEK
Omsætning
1,09 mio.
EBIT %
-711,93 %
P/E
-
Udbytteafkast, %
-
Finanskalender
26.8
2025
Delårsrapport Q2'25
25.11
2025
Delårsrapport Q3'25
Alle
Selskabsmeddelelser
ViserAlle indholdstyper
DBP: Double Bond Pharmaceutical International AB (publ) Qualifies New Swedish EU-GMP-Approved Supplier for Key Component of SI-053
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools